Differential Visualization of Dopamine D2 and D3 Receptor Sites in Rat Brain. A Comparative Study UsingIn SituHybridization Histochemistry and Ligand Binding Autoradiography-Reference-Cited by-同舟云学术

Differential Visualization of Dopamine D2 and D3 Receptor Sites in Rat Brain. A Comparative Study UsingIn SituHybridization Histochemistry and Ligand Binding Autoradiography

Published:1993-02 Issue:2 Volume:5 Page:145-153
ISSN:0953-816X
Container-title:European Journal of Neuroscience
language:en
Short-container-title:

Author:

Landwehrmeyer B.,Mengod G.,Palacios J. M.

Publisher

Wiley

Subject

General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1460-9568.1993.tb00480.x/fullpdf

Reference41 articles.

1. A detailed mapping of dopamine D2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride;Bouthenet;Neuroscience,1987

2. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA;Bouthenet;Brain Res.,1991

3. Cloning and expression of a rat D2 dopamine receptor cDNA;Bunzow;Nature,1988

4. Dopamine D2 receptors in the rat brain: autoradiographic visualization using a high-affinity selective agonist ligand;Charuchinda;J Neurosci.,1987

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early-life risperidone alters locomotor responses to apomorphine and quinpirole in adulthood;Behavioural Brain Research;2024-09

2. Current Perspectives on Selective Dopamine D3 Receptor Antagonists/Partial Agonists as Pharmacotherapeutics for Opioid and Psychostimulant Use Disorders;Therapeutic Applications of Dopamine D3 Receptor Function;2022

3. The Development of the Mesoprefrontal Dopaminergic System in Health and Disease;Frontiers in Neural Circuits;2021-10-12

4. Can pharmacotherapy improve treatment outcomes in people with co-occurring major depressive and cocaine use disorders?;Expert Opinion on Pharmacotherapy;2021-06-23

5. Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia;Biomedicines;2021-03-19